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Serum cholesterol, haemorrhagic stroke, ischaemic stroke, and
myocardial infarction: Korean national health system prospective
cohort study
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Abstract
Objective To investigate risk factors, such as heavy alcohol
consumption, that might explain any increased risk of
haemorrhagic stroke associated with low blood cholesterol.
Design Prospective cohort study.
Setting Korea.
Participants 787 442 civil servants (661 700 men, 125 742
women) aged 30-64.
Main outcome measures Cardiovascular risk factors were
assessed at biennial health check. Data on morbidity and
mortality were ascertained from 1990 to 2001 using hospital
admissions and mortality surveillance systems.
Results 6328 cases of ischaemic stroke (6021 men, 307
women), 3947 cases of haemorrhagic stroke (3748 men, 199
women), 3170 cases of undefined stroke (2902 men, 268
women), and 4417 cases of myocardial infarction (4305 men,
112 women) occurred. Ischaemic stroke and myocardial
infarction were strongly and positively associated with blood
cholesterol (hazard ratio per 1 mmol/l cholesterol 1.20 (95%
confidence 1.16 to 1.24) and 1.48 (1.43 to 1.53), respectively).
Haemorrhagic stroke showed an inverse association in fully
adjusted models (0.91, 0.87 to 0.95). This inverse association
was confined to participants with hypertension. When stratified
by concentration of  glutamyl transferase (GGT), an indicator
of alcohol consumption, the association was not seen in
participants with low concentrations of GGT, and it was
independent of hypertension in those with high concentrations
of GGT ( > 80 U/l).
Conclusion High alcohol consumption may underlie the
association between low blood cholesterol and increased risk of
haemorrhagic stroke.
Introduction
Stroke is the third most common cause of death and a leading
cause of severe disability in both the developed and developing
world.1 The burden of stroke is becoming greater as the popula-
tion ages, making its prevention a priority.
Mortality from haemorrhagic stroke declined consistently
over the 20th century in many countries, but ischaemic stroke
showed a rise and a fall, mirroring the coronary heart disease
epidemic.2 These different secular trends indicate that the risk
factors for the two subtypes of stroke may differ. Changes in
major cardiovascular risk factors may explain up to two thirds of
the decline in mortality from stroke.3 4 In Japan, even though
concentrations of blood cholesterol rose from the 1960s to the
1980s, rates of ischaemic and haemorrhagic stroke have fallen
dramatically.5 6 The importance of individual risk factors can be
determined only by examining the different subtypes of stroke.
The role of blood cholesterol as a cause of stroke remains
uncertain.7–9 The lack of an association between all types of
stroke and concentrations of cholesterol may mask a positive
association with ischaemic stroke and an inverse association with
haemorrhagic stroke, although the relation with haemorrhagic
stroke may not be causal.10–13 Studies of different populations
give imprecise estimates of the association between cholesterol
and subtypes of stroke.14–16 The inverse association between
serum cholesterol and haemorrhagic stroke may be specific to
men with hypertension; this has led to speculation that heavy
alcohol consumption underlies hypertension, hypocholestero-
laemia, and increased risk of haemorrhagic stroke.17
This uncertainty causes concern that treatment to lower cho-
lesterol might increase risk of haemorrhagic stroke.18 A recent
review of randomised trials found no influence of such treatment
on haemorrhagic stroke (relative risk 1.05, 95% confidence
interval 0.78 to 1.41, for a 1 mmol/l lowering of low density lipo-
protein cholesterol).19 However, only 204 cases (105 in the treat-
ment group; 99 in the control group) were used to estimate the
risk of haemorrhagic stroke, and confidence intervals were wide.
We aimed to resolve this uncertainty by investigating the associa-
tion of blood cholesterol with stroke subtype in a large cohort of
Korean civil servants.
Methods
Participants and study measures
Participants were Korean male and female public servants aged
30-64, who had a health check provided by the Korean Medical
Insurance Corporation between 1986 and 1990. In Korea, medi-
cal insurance is provided to everyone under the Korean national
health system. The Korea Medical Insurance Corporation was
one of the main national health insurance institutions at the time
and was in charge of medical insurance services provided to all
public servants and their unemployed family members. In total,
902 222 people were examined (95% of all public servants). We
excluded 93 540 people who changed job or had a myocardial
infarction or stroke between 1986 and 1990, and 21 240 people
who lack data on blood cholesterol; this left a study population of
787 442 (661 700 men, 125 742 women). Details of the study
measurements have been published.20 Extra information on risk
factors was obtained from the biennial multiphasic health
examination and a self administered questionnaire. We excluded
measures taken after a cardiovascular event for people who had
Cite this article as: BMJ, doi:10.1136/bmj.38855.610324.80 (published 6 June 2006)
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such an event during the study, and we used mean values
between 1986 and 1996 for measures that were repeated.
Initially we classified participants into three groups
according to the ATP III (adult treatment panel III) classification
of cholesterol concentrations (low, medium, or high: < 5.16
mmol/l, 5.17-6.20 mmol/l, or ≥ 6.21 mmol/l).21 We further
divided the lower and the higher groups to give six groups in
total (table 1).
We categorised fasting glucose concentrations as normal
( < 7.0 mmol/l) or high ( ≥ 7.0 mmol/l). Blood pressure was
measured at each examination and classified as normal or
prehypertensive ( < 140/ < 90 mm Hg) or hypertensive ( ≥ 140
or ≥ 90 mm Hg).22 Participants who had a recorded diagnosis of
hypertension on more than two occasions were also classified as
hypertensive.
We classified smoking habits as never smoked, ex-smoker,
1-19 cigarettes a day, or ≥ 20 cigarettes a day. Physical exercise
was categorised as did or did not do regular exercise. Alcohol
consumption was categorised as < 30, 30-104, 105-209, 210-419,
or ≥ 420 g/week. We also measured  glutamyl transferase
(GGT) as a proxy of alcohol intake (Spearman’s correlation coef-
ficient 0.40 between self reported alcohol consumption and
GGT values; P < 0.0001). Because participants (especially heavy
drinkers) may under-report alcohol consumption, we stratified
the analyses by each measure.
Hepatitis B virus antigen seropositivity was determined by
reverse haemagglutination or enzyme linked immunoassay. Eco-
nomic status was grouped into four categories on the basis of
monthly salary in 1990.
Follow-up of mortality and morbidity from stroke
All myocardial infarctions, non-fatal strokes, and fatal strokes
occurring between 1 August 1990 and 31 July 2001 were
included. We used the following codes in ICD-10 (international
classification of diseases, 10th revision) to identify and classify
myocardial infarction and stroke: myocardial infarction (I21-
I24), all stroke (I60-I69), ischaemic stroke (I63, I67.8), and haem-
orrhagic stroke (I61). Transient ischaemic attacks and subarach-
noid haemorrhages were excluded. We ascertained fatal cases
from the Korean national statistical office and the death benefit
record of the Korean national health system. Morbidity was
ascertained from hospital admissions. Patients with non-fatal
disease had probably been admitted to hospital at some stage of
their illness because public servants have easy access to hospital
care and we followed up the participants for 10 years.
Analytical methods
Follow-up began in August 1990, and the participants were cen-
sored at the date of admission or death attributable to stroke or
myocardial infarction or other causes of death, or at 31 July 2001
if no censoring event occurred. We used Cox proportional haz-
ards regression analysis to assess hazard ratios for myocardial
infarction and subtypes of stroke according to concentrations of
serum cholesterol. Results of Weibul regression analysis were
compared for models where the proportionality assumption was
not upheld. We used regression models for myocardial
infarction, all stroke, ischaemic stroke, and haemorrhagic stroke,
initially adjusting for age and sex and then for all covariates. To
identify any effect of pre-existing occult disease, we repeated
analyses after excluding events in the first five years of follow-up.
We also stratified by presence or absence of hypertension and by
Table 1 Associations between cardiovascular risk factors and cholesterol concentrations. Korean national health system study, 1986-2001. Values are mean
(SD) unless stated otherwise
Risk factors No of participantsavailable
Serum cholesterol concentration (mmol/l)
≤3.36 (n=8319)
3.36-4.13 (n=105
293)
4.14-5.16 (n=415
744)
5.17-6.20 (n=217
158)
6.21-6.97 (n=32
945) ≥6.98 (n=7983)
Age (years) 787 442 40.1 (9.3) 39.9 (8.5) 41.8 (8.6) 43.8 (8.7) 45.4 (8.8) 46.1 (8.9)
Systolic blood pressure (mm Hg) 787 418 119.5 (13.4) 119.8 (12.5) 122.4 (12.8) 125.6 (13.7) 128.5 (14.7) 130.7 (16.0)
Diastolic blood pressure (mm Hg) 787 414 77.8 (9.3) 78.1 (8.5) 79.9 (8.6) 82.1 (8.9) 84.0 (9.4) 85.3 (10.1)
Body mass index 744 873 21.7 (2.2) 22.2 (2.3) 22.9 (2.4) 23.7 (2.4) 24.2 (2.4) 24.3 (2.4)
Glucose ≥7 mmol/l (%) 787 431 3.3 2.1 2.8 5.1 8.9 14.9
 glutamyl transferase (U/l)* 500 419 36.2 (68.5) 33.9 (55.0) 38.8 (53.3) 48.0 (59.8) 59.2 (72.3) 76.8 (99.7)
 glutamyl transferase >80 U/l*, n (%) 500 419 286 (7.8) 4 491 (6.9) 23 663 (8.7) 18 072 (13.1) 3 641 (19.1) 1082 (26.6)
≥20 cigarettes a day, n (%) 744 413 552 (8.7) 9 511 (9.8) 46 566 (11.8) 29 581 (14.2) 5 014 (16.3) 1258 (17.7)
No alcohol, n (%) 722 662 3643 (62.4) 52 523 (56.3) 198 096 (51.4) 97 533 (48.2) 14 137 (47.9) 3221 (48.2)
Alcohol <30 g/week, n (%) 722 662 3868 (66.3) 56 388 (60.4) 213 967 (55.6) 105 916 (52.4) 15 234 (51.6) 3422 (51.2)
Alcohol ≥210 g/week, n (%) 722 662 798 (13.7) 14 101 (15.1) 66 798 (17.3) 38 697 (19.1) 5 757 (19.5) 1450 (21.7)
Regular exercise, n (%) 742 973 932 (14.7) 15 489 (16.0) 69 324 (17.6) 39 345 (19.0) 5 800 (18.9) 1325 (18.7)
Lowest income group, n (%) 787 442 4430 (53.3) 38 469 (36.5) 123 498 (29.7) 57 240 (26.4) 9 052 (27.5) 2518 (31.5)
*Excluding participants positive for hepatitis B or of unknown status.
All risk factors were significantly different across concentrations of serum cholesterol (P<0.001) by 2 test, Mantel-Haenszel 2 test, and ANOVA.
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Fig 1 Fully adjusted risk of stroke in the Korean national health system study,
1986-2001
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both blood pressure and blood GGT concentrations (as a proxy
for alcohol consumption) to evaluate the association between
cholesterol and haemorrhagic stroke. We excluded 213 921 par-
ticipants who had no GGT value or were positive or not tested
for hepatitis B. The distribution of age adjusted risk factors and
cholesterol associations were similar for participants who were
excluded and those who were included. We could not perform
sex specific analyses because female public servants were fewer
and younger than their male counterparts.
Results
Of the 787 442 participants (661 700 men and 125 742 women),
6328 (6021 men and 307 women) had an ischaemic stroke, 3947
(3748 men and 199 women) a haemorrhagic stroke, 3170 (2902
men, 268 women) an undefined stroke, and 4417 (4305 men and
112 women) a myocardial infarction. Table 1 shows the distribu-
tion of risk factors according to serum cholesterol group. Partici-
pants with the highest concentrations of cholesterol were older
and had higher blood pressure, greater body mass index, and
higher fasting serum glucose values than those with lower
cholesterol concentrations. Reporting of heavy drinking ( ≥ 210
g alcohol/week) was more prevalent among participants with
higher concentrations of serum cholesterol. GGT concentration
showed a J shaped association with blood cholesterol.
Table 2 shows the associations between serum cholesterol
and stroke subtypes and myocardial infarction. All strokes
showed a trend of increasing risk with higher cholesterol
concentration (hazard ratio for highest versus lowest groups, age
and sex adjusted 2.55, 95% confidence interval 2.04 to 3.20), but
this was greatly attenuated when adjusted for other covariates
(1.13, 0.87 to 1.48). Examining the associations with ischaemic
stroke showed a strong, linear association with serum cholesterol
(age and sex adjusted 4.54, 3.07 to 6.70). Full adjustment for cov-
ariates attenuated the association with ischaemic stroke but did
not completely remove this association (1.67, 1.07 to 2.61). The
association with haemorrhagic stroke was non-linear, with weak
evidence of an increased risk in both the lowest and the highest
serum cholesterol groups. The fully adjusted hazard ratios of
ischaemic stroke and myocardial infarction for each 1 mmol/l
increase in serum cholesterol were 1.20 (1.16 to 1.24) and 1.48
(1.43 to 1.53). Full adjustment for covariates completely
Table 2 Risk of stroke and myocardial infarction in Korean national health system study, 1986-2001.* Values are hazard ratios (95% confidence interval)
unless stated otherwise
Serum cholesterol
(mmol/l) No of participants
Stroke
Myocardial infarction
All† Ischaemic Haemorrhagic
Age and sex adjusted model
n=13 445 n=6328 n=3947 n=4417
<3.36 8 319 1.00 1.00 1.00 1.00
3.36- 105 293 1.10 (0.89 to 1.35) 1.30 (0.89 to 1.90) 0.87 (0.63 to 1.19) 1.06 (0.68 to 1.66)
4.14- 415 744 1.13 (0.93 to 1.38) 1.69 (1.17 to 2.44) 0.81 (0.59 to 1.09) 1.42 (0.92 to 2.19)
5.17- 217 158 1.35 (1.10 to 1.65) 2.33 (1.61 to 3.35) 0.86 (0.63 to 1.17) 2.44 (1.59 to 3.75)
6.21- 32 945 1.79 (1.45 to 2.20) 3.39 (2.33 to 4.92) 0.98 (0.71 to 1.37) 3.89 (2.51 to 6.03)
≥6.98 7 983 2.55 (2.04 to 3.20) 4.54 (3.07 to 6.70) 1.56 (1.08 to 2.24) 6.25 (3.98 to 9.82)
Per 1 mmol/l increase‡ 1.22 (1.19 to 1.24) 1.41 (1.37 to 1.45) 1.04 (1.00 to 1.09) 1.66 (1.61 to 1.71)
Fully adjusted model§
n=11 704 n=5676 n=3345 n=4004
<3.36 5 477 1.00 1.00 1.00 1.00
3.36- 91 367 0.83 (0.65 to 1.07) 0.90 (0.59 to 1.39) 0.76 (0.51 to 1.14) 0.89 (0.51 to 1.56)
4.14- 379 907 0.75 (0.59 to 0.96) 0.98 (0.64 to 1.49) 0.61 (0.41 to 0.91) 1.06 (0.62 to 1.84)
5.17- 199 523 0.77 (0.60 to 0.98) 1.14 (0.75 to 1.73) 0.55 (0.37 to 0.83) 1.62 (0.94 to 2.80)
6.21− 28 949 0.89 (0.69 to 1.15) 1.46 (0.96 to 2.24) 0.52 (0.34 to 0.79) 2.30 (1.32 to 4.00)
≥6.98 6 484 1.13 (0.87 to 1.48) 1.67 (1.07 to 2.61) 0.80 (0.50 to 1.26) 3.40 (1.93 to 5.99)
Per 1 mmol/l increase 1.05 (1.03 to 1.08) 1.20 (1.16 to 1.24) 0.91 (0.87 to 0.95) 1.48 (1.43 to 1.53)
*All strokes ICD I60-I69; ischaemic strokes ICD I63, I67.8; haemorrhagic strokes ICD I61; myocardial infarction ICD I21-I24.
†Includes unidentified strokes: 3170 cases (2902 men, 268 women) in the age and sex adjusted model and 2683 (2426 men, 257 women) in the fully adjusted model.
‡Participants with data on all covariates used in fully adjusted models.
§Adjusted for age, sex, body mass index, height, serum glucose, hypertension, ethanol consumption, smoking, physical activity, monthly pay, and area of residence.
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attenuated the increased risk in the highest cholesterol group (fig
1).
The pattern was similar when we excluded events during the
first five years of follow-up. Stratifying by presence or absence of
hypertension showed that the inverse association with choles-
terol was confined to people with hypertension (fig 2). In such
participants, the hazard ratio for haemorrhagic stroke was 0.89
(0.84 to 0.94) for each 1 mmol/l increase in serum cholesterol.
Participants without hypertension showed no evidence of
increased risk of haemorrhagic stroke, but confidence intervals
were wide.
GGT was positively associated with haemorrhagic stroke
(2.02, 1.74 to 2.34; table 3) and inversely associated with myocar-
dial infarction, indicating a protective effect of alcohol. When
stratified by GGT concentrations (low ( ≤ 45 U/l), intermediate
(46-80 U/l) and high ( ≥ 81 U/l)), the inverse association was
confined to participants in the intermediate and high groups
and was seen only in hypertensive participants (fig 3). When the
analysis was stratified by self reported alcohol consumption
( < 30, 30-209, ≥ 210 g/week), the pattern was similar but the
results were less clear than when stratified by GGT. The results
were the same when we excluded 1% of the highest values for
cholesterol and alcohol consumption.
Discussion
Our study included almost 4000 cases of haemorrhagic stroke,
investigated a wide range of covariates including socioeconomic
factors, and explored risk of haemorrhagic stroke at low concen-
trations of cholesterol. We found an association between
haemorrhagic stroke and low serum cholesterol only in partici-
pants with hypertension, suggesting that hypertension may
modify the effects of low cholesterol.
The results of observational studies can be misleading
because of cumulative effects of residual confounding.23 We
believe our results are robust, given the specificity of the result,
agreement with the randomised evidence, and adjustment for a
wide range of covariates.
The contribution of alcohol
GGT reflects alcohol consumption and might be a better meas-
ure than self reporting.24 Raised GGT concentrations were
caused mainly by hepatitis infection, alcohol consumption, and
body mass index, so we excluded hepatitis carriers and adjusted
for body mass index. Our finding that GGT was positively associ-
ated with haemorrhagic stroke and inversely associated with
myocardial infarction agrees with earlier studies and validates
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Fig 3 Fully adjusted risk for haemorrhagic stroke after participants who were seropositive for hepatitis B were excluded. Korean national health system study,
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Table 3 Risk of stroke and myocardial infarction in Korean national health
system study, 1986-2001. Values are fully adjusted hazard ratios (95%
confidence interval)
 glutamyl
transferase
(U/l)
Stroke Myocardial infarction
(n=1430)Ischaemic (n=2067) Haemorrhagic (n=1066)
≤45 1.00 1.00 1.00
46-80 1.14 (1.02 to 1.27) 1.11 (0.94 to 1.32) 0.85 (0.75 to 0.98)
≥81 1.11 (0.99 to 1.25) 2.02 (1.74 to 2.34) 0.67 (0.57 to 0.79)
Ischaemic stroke ICD I63, I67.8; haemorrhagic stroke ICD I61; myocardial infarction ICD
I21-I24.
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the use of GGT as a marker of alcohol intake, especially for heavy
drinkers.25 Previous studies have shown that people with low
cholesterol concentrations are more likely to be heavy drinkers.26
Hypertension and other effects of alcohol could explain the
increased risk of haemorrhagic stroke.27 In our study, increased
risk of haemorrhagic stroke in people with low concentrations of
blood cholesterol ( < 4.14 mmol/l) was restricted to those with
high GGT values; this relation was less evident when alcohol
consumption was measured by self report. The measures of
blood pressure might not have been a true reflection of risk, as
transient high blood pressure associated with binge drinking
may have an important role in haemorrhagic stroke.25 At low
concentrations of GGT, low serum cholesterol was not associated
with a higher risk of haemorrhagic stroke. In effect, low blood
cholesterol may act as a marker of the health damaging effects of
alcohol, rather than be a cause of haemorrhagic stroke.
Limitations
All information was routinely collected. However, assessments of
the quality of cholesterol assays are high.28
Errors may have been made in assigning the subtype of
stroke. However, neuroimaging studies were conducted in 89%
of hospital admissions for stroke between 1999 and 2000 in
Korea.15 Since the early 1980s, computed tomography has been
incorporated into the routine diagnosis of stroke in Korea, and a
high rate of neuroimaging can be expected in our study.29
The high ratios of stroke to myocardial infarction and haem-
orrhagic stroke to ischaemic stroke in our study are consistent
with current data from Korea. Cause specific mortality was 73.8/
100 000 for stroke and 21.9/100 000 for myocardial infarction
in 2001, and an independent study showed a similar
composition of subtypes of stroke (143 cases (41%) of
haemorrhagic stroke and 205 cases (59%) of ischaemic stroke
among the validated 348 cases of stroke).30 31
Our use of an occupational cohort might result in healthy
worker effects (the general population includes healthy and sick
people, whereas workers have at least a minimum level of
health), although these should not influence associations
between risk factors and outcomes. Heavy drinkers might have
been excluded from the workforce, but this would have
attenuated the observed associations.
Implications
Low blood cholesterol may not in itself increase risk of haemor-
rhagic stroke. Blood cholesterol values in the range likely to be
achieved by treatment with statins are not associated with
increased risk of haemorrhagic stroke. In countries with high
rates of haemorrhagic stroke, preventive strategies that include
lowering blood cholesterol should not be tempered because of
concerns about a possible increased risk of haemorrhagic stroke.
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